Supriya Ghosh (Editor)

Thiocolchicoside

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Routes of administration
  
Oral, Topical, IM

Biological half-life
  
5-6 hours

Bioavailability
  
25%

ATC code
  
M03BX05 (WHO)

CAS Number
  
602-41-5

Molar mass
  
563.618 g/mol

Thiocolchicoside

AHFS/Drugs.com
  
International Drug Names

Legal status
  
In general: ℞ (Prescription only)

Thiocolchicoside


Thiocolchicoside (Muscoril, Myoril, Neoflax) is a muscle relaxant with anti-inflammatory and analgesic effects. It acts as a competitive GABAA receptor antagonist and also glycine receptor antagonist with similar potency and nicotinic acetylcholine receptors to a much lesser extent. It has powerful convulsant activity and should not be used in seizure-prone individuals.

Contents

Aceclofenac and thiocolchicoside carton


Side effects

Side effect of thiocolchicoside can include nausea, allergy and vasovagal reactions.

Although muscle relaxants may have the major side effect of sedation, thiocholchicoside is free from sedation effects possible due to non-interference with nicotinic receptors.

Pharmacokinetics

Thiocolchicoside is broken down in the body to a metabolite called 3-demethylthiocolchicine (also known as SL59.0955 or M2) that could damage dividing cells therefore inducing toxicity in the embryo, neoplastic changes and fertility reduction in males. Therefore, recommended oral dose should not exceed 7 days and intramuscular dose duration should not exceed 5 days. Local skin preparations are less toxic.

References

Thiocolchicoside Wikipedia